The candidate is an MD trained clinical neurologist whose career goal is to investigate the pathophysiologic causes of Alzheimer's disease, with emphasis on studying Amyloid-Beta metabolism in humans. The proposed period of mentored scientific training in the laboratory of Dr. David Holtzman and clinical research training with Dr. John Morris at Washington University will allow the candidate to develop the skills necessary to become an independent investigator. The central hypotheses that will be tested during the proposed project are as follows: 1) Alzheimer's disease is associated with increased synthesis and/or decreased clearance of the amyloid-beta peptide (A?) in humans. 2) The risk factor of increased age is associated with increased synthesis and/or decreased clearance of Abeta in humans. 3) The risk factor of ApoE4 genotype is associated with decreased clearance of Abeta in humans. The candidate proposes to test these hypotheses using a recently developed method to measure the synthesis and clearance rate of A? in vivo in humans. Participants from the Washington University Alzheimer's Disease Research Center will be enrolled in the above studies to compare groups of 1) AD versus non-demented controls, 2) older age, middle age, vs. younger age, and 3) ApoE4 positive vs. ApoE4 negative. A detectable change in Abeta metabolism in humans that is associated with AD may ultimately lead to better diagnostic and therapeutic options.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08AG027091-01
Application #
7011102
Study Section
Special Emphasis Panel (ZAG1-ZIJ-3 (02))
Program Officer
Phelps, Creighton H
Project Start
2005-09-30
Project End
2008-08-31
Budget Start
2005-09-30
Budget End
2006-08-31
Support Year
1
Fiscal Year
2005
Total Cost
$170,262
Indirect Cost
Name
Washington University
Department
Neurology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Lucey, Brendan P; Gonzales, Celedon; Das, Ujjwas et al. (2015) An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-? concentrations collected by lumbar puncture and indwelling lumbar catheter. Alzheimers Res Ther 7:53
Dobrowolska, Justyna A; Kasten, Tom; Huang, Yafei et al. (2014) Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system. PLoS One 9:e89998
Roberts, Kaleigh Filisa; Elbert, Donald L; Kasten, Tom P et al. (2014) Amyloid-? efflux from the central nervous system into the plasma. Ann Neurol 76:837-44
Huang, Yafei; Potter, Rachel; Sigurdson, Wendy et al. (2012) ?-amyloid dynamics in human plasma. Arch Neurol 69:1591-7
Huang, Yafei; Potter, Rachel; Sigurdson, Wendy et al. (2012) Effects of age and amyloid deposition on A? dynamics in the human central nervous system. Arch Neurol 69:51-8
Mawuenyega, Kwasi G; Sigurdson, Wendy; Ovod, Vitaliy et al. (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330:1774
Cook, Jacquelynn J; Wildsmith, Kristin R; Gilberto, David B et al. (2010) Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound. J Neurosci 30:6743-50
Bateman, Randall J; Munsell, Ling Y; Chen, Xianghong et al. (2007) Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates. J Am Soc Mass Spectrom 18:997-1006
Bateman, Randall J; Wen, Guolin; Morris, John C et al. (2007) Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. Neurology 68:666-9
Bateman, Randall J; Eidelberg, David (2007) Testing a test for Alzheimer disease. Neurology 68:482-3

Showing the most recent 10 out of 12 publications